Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, High-Grade”

649 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 649 results

Testing effectiveness (Phase 2)Looking for participantsNCT06249191
What this trial is testing

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaHigh Grade B-Cell Lymphoma
OHSU Knight Cancer Institute 30
Not applicableLooking for participantsNCT07176624
What this trial is testing

The PRE-VAIL Study

Who this might be right for
ARDS (Moderate or Severe)Prone PositionEnteral Nutrition Feeding+1 more
The First Hospital of Jilin University 259
Not applicableStudy completedNCT02184442
What this trial is testing

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

Who this might be right for
SevereSymptomaticCalcific Aortic Stenosis
Edwards Lifesciences 560
Not applicableStudy completedNCT01760915
What this trial is testing

University of Wisconsin Severe Asthma Research Program III

Who this might be right for
Asthma
University of Wisconsin, Madison 107
Testing effectiveness (Phase 2)Ended earlyNCT05156125
What this trial is testing

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Oppilan Pharma Ltd 213
Not applicableStudy completedNCT05169203
What this trial is testing

The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study

Who this might be right for
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Cell of OriginDiffuse Large B-cell Lymphoma Recurrent
Herlev Hospital 2,969
Testing effectiveness (Phase 2)Ended earlyNCT02201524
What this trial is testing

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Pfizer 59
Early research (Phase 1)Active Not RecruitingNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 34
Not applicableNot Yet RecruitingNCT06958770
What this trial is testing

Combining Electrical Impedance Tomography and Thoracic Ultrasound Toinvestigate Dynamic Changes

Who this might be right for
ARDS (Moderate or Severe)
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableActive Not RecruitingNCT04567394
What this trial is testing

Cannabis Use Disorder Treatment Study

Who this might be right for
Cannabis Use Disorder, MildCannabis Use Disorder, ModerateCannabis Use Disorder, Severe
The University of Tennessee, Knoxville 1,077
Not applicableStudy completedNCT02208531
What this trial is testing

Transition to Scale of Nutrition and Psychosocial Stimulation Program for Malnourished Children

Who this might be right for
Moderate and Severe Undernutrition
International Centre for Diarrhoeal Disease Research, Bangladesh 6,400
Testing effectiveness (Phase 2)Study completedNCT00975975
What this trial is testing

Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more
Indiana University 17
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT01371630
What this trial is testing

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeBurkitt-Like Lymphoma With 11q Aberration+6 more
M.D. Anderson Cancer Center 276
Testing effectiveness (Phase 2)Looking for participantsNCT05951777
What this trial is testing

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
Hope Biosciences LLC 51
Not applicableLooking for participantsNCT06941194
What this trial is testing

Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery

Who this might be right for
SarcomaSarcoma,Soft Tissue
Istituto Oncologico Veneto IRCCS 48
Post-approval studies (Phase 4)Study completedNCT02328651
What this trial is testing

Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth Disease

Who this might be right for
Handfoot-mouth Disease
Children's Hospital of Fudan University 24
Testing effectiveness (Phase 2)Study completedNCT00727324
What this trial is testing

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AM-Pharma 22
Early research (Phase 1)Study completedNCT02323880
What this trial is testing

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Who this might be right for
Malignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more
Children's Oncology Group 59
Load More Results